RPL12P26

Across TCGA pan-cancer cohorts, RPL12P26 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL12P26’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPL12P26 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL12P26 is over-expressed in tumor.

UCEC and LUAD are the cancer types where RPL12P26 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL12P26 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.207	.043	4	view →
LUAD	All	II,III,IV	+0.051	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL12P26–UCEC

Open the UCEC breakdown →